New
risk factors of metabolic syndrome
and DM Co-chair
by: P. Gambert
(France) & M. Rouis
(France)
Metabolic
syndrome and type 2 diabetes:
can we reduce the cardiovascular
risk? .............................................................................................
R. Carmena (Spain)
Adiponectin,
diabesity and the metabolic syndrome
............................................................................
P. Froguel (France)
Apolipoprotein
A-V: new findings .................................................................................................
J. Fruchart-Najib (USA)
Inflammation
in diabetes mellitus and atherosclerosis
-
further support for the "common
soil" hypothesis? .........................................................................
W. Koenig (Germany)